Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReNEW: Autologous Bone Marrow Mononuclear Cells in Acute MI
NCT00691834Phase 2Withdrawn
- Sponsor
- Duke University
- Start
- Aug 2009
- Primary completion
- Aug 2009
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in acute myocardial infarction (AMI), sponsored by Duke University. Planned start Aug 2009; status: withdrawn.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT00691834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00691834.